EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Kidney transplantation in patients on anti‐tubercular therapy: A single centre observational study

Pallavi Prasad iD, Sahil Bagai, Vandana Prasad, Rahul Grover, Gagandeep Chhabra, Dinesh Khullar iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14242 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Pallavi Prasad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Kidney Transplantation, Antitubercular Agents, Tuberculosis, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) is a common infection in chronic kidney disease. The prolonged therapy of TB can delay kidney transplantation in patients on antitubercular therapy (ATT).

Methods

This was a retrospective single‐center study to analyze the safety of kidney transplantation and its outcomes in patients undergoing transplantation while on the continuation phase of ATT.

Results

Between 2013 and 2022, 30 patients underwent kidney transplantation while on ATT. Median age was 38 years and 70% were males. Majority of the patients (86.7%) had extrapulmonary tuberculosis, most common site of involvement being tubercular lymphadenitis. 14/30 patients had microbiological/histopathological diagnosis of TB and the rest were diagnosed by ancillary tests. Patients were treated with 4 drug ATT (isoniazid, rifampicin, pyrazinamide, ethambutol) before transplantation for aminimum of 2 months. Post‐transplantation fluoroquinolone‐based non‐rifamycin ATT was used (median duration 11 months). All patients completed therapy. At 2 years, there was 100% patient survival and 96.7% graft survival. Median eGFR at 6, 12, and 24 months post‐transplantation was 71.9, 64.7, and 67 mL/min/1.73m 2 , respectively. The percentage of patients suffering a biopsy proven acute rejection at 6, 12, and 24 months was 3.3%, 6.7%, and 6.7%.

Conclusion

Kidney transplantation can be done in patients with TB who have a satisfactory response to the intensive phase of the ATT. The decision for transplantation while on the continuation phase of ATT should be individualized. In our experience, there is excellent patient and graft survival in these patients with a low risk of failure of ATT or relapse of TB. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationAntitubercular AgentsTuberculosisGraft RejectionHumansMaleFemaleAdultRetrospective StudiesMiddle AgedGraft SurvivalTreatment OutcomePyrazinamideEthambutolYoung AdultKidney Failure, ChronicRifampin

Stichwörter der Autor:innen

anti‐tubercular therapytransplantationtuberculosis

Substanzen

Antitubercular AgentsPyrazinamideEthambutolRifampin

Autor:innen und Institutionen

  • Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
  • Department of Nephrology and Renal Transplant Medicine, Max Superspeciality Hospital, Saket, New Delhi, India.

ORCID-Profile: Pallavi Prasad, Dinesh Khullar

Zitieren

APA

Prasad, P., Bagai, S., Prasad, V., Grover, R., Chhabra, G., & Khullar, D. (2024). Kidney transplantation in patients on anti‐tubercular therapy: A single centre observational study. Transplant Infectious Disease. https://doi.org/10.1111/tid.14242

Vancouver

Prasad P, Bagai S, Prasad V, Grover R, Chhabra G, Khullar D. Kidney transplantation in patients on anti‐tubercular therapy: A single centre observational study. Transplant Infectious Disease. 2024. doi:10.1111/tid.14242

BibTeX
@article{Prasad2024,
  author = {Prasad, Pallavi and Bagai, Sahil and Prasad, Vandana and Grover, Rahul and Chhabra, Gagandeep and Khullar, Dinesh},
  title = {Kidney transplantation in patients on anti‐tubercular therapy: A single centre observational study},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14242}
}
Kostenlos starten →